Microalgae-derived ingredient specialists Algatech are to license the rights to the production of β-1,3-glucan from microalgae Euglena gracilis from US biotech firm F3 Platform Biologics.
NutraIngredients speaks to the top investors in the food and nutrition space to find out how entrepreneurs can get their big ideas onto pitching tables.
The food and nutrition space is hit by hundreds of innovations every day and investors in the field are being inundated with startup hopefuls wanting to pitch the next big thing for the market.
AB-Biotics is the subject of a €38m takeover bid by its largest shareholder Kaneka Europe, who are looking to acquire the remaining 60% of the Spanish probiotic specialists, valuing the firm at €63m.
French microalgae specialists Microphyt take a forward step in its expansion plans with €28.5m raised in its latest funding round that reaffirms investor confidence in the microalgae sector.
Venture capital firm Seventure Partners announce the creation of a fund to invest in start-up companies and SMEs that focus on sports-related food or nutrition products.
DuPont Nutrition & Health and Industrial Biosciences Businesses are to merge in €5.6bn creation of the Nutrition & Biosciences business unit spread across 70 manufacturing sites and 25 innovation centres worldwide.
Poland’s Office of Competition and Consumer Protection (UOKiK) is to initiate proceedings against Solgar Polska after the authority accuse the firm of supplement price-fixing within the country.
With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
Chilean omega-3 concentrates manufacturer Golden Omega has acquired OmegaTri AS, the Norwegian developer of an innovative omega-3 compressible powder technology.
Official controls on supplements sold over the Internet remain ‘limited,’ a European Commission (EC) report concludes, with non-compliance mainly related to labelling and health claim requirements.
Nordic food and ingredients group Orkla today (29 March) unveiled a slate of acquisitions that, it said, reflected its strategy to invest behind priority areas.
The supply of dietary ingredients is an earnings bright spot for Innophos as the company continues to transform from commodity chemicals supplier into a nutritional player.
Microbiome science is mature enough to enter the pharma field, according to the CEO of a microbiota-focused drug developer, who presented at Probiota Copenhagen earlier this month.
DuPont Nutrition & Health and Lonza Consumer Health & Nutrition are to join forces to manufacture and supply human milk oligosaccharide (HMO) in a deal that looks to meet rising demand in a €44bn global infant nutrition sector.
Glanbia plc released its 2018 financials this week, revealing growing profits on the back of a few high-profile acquisitions. The nutritional ingredients and dairy business is dipping into the non-dairy sector and reorganizing its board of directors in...
